-
1
-
-
33645099547
-
Interleukin-6 attenuates the development of experimental diabetes-related neuropathy
-
Andriambeloson E, Baillet C, Vitte P A et al. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology: 2006; 26 32 42
-
(2006)
Neuropathology
, vol.26
, pp. 32-42
-
-
Andriambeloson, E.1
Baillet, C.2
Vitte, P.A.3
-
2
-
-
47949102112
-
Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy
-
Bordet T, Buisson B, Michaud M et al. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. J Pharmacol Exp Ther: 2008; 326 623 632
-
(2008)
J Pharmacol Exp Ther
, vol.326
, pp. 623-632
-
-
Bordet, T.1
Buisson, B.2
Michaud, M.3
-
3
-
-
20144389536
-
Diabetic neuropathies: A statement by the American Diabetes Association
-
DOI 10.2337/diacare.28.4.956
-
Boulton A J, Vinik A I, Arezzo J C et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care: 2005; 28 956 962 (Pubitemid 40434506)
-
(2005)
Diabetes Care
, vol.28
, Issue.4
, pp. 956-962
-
-
Boulton, A.J.M.1
Vinik, A.I.2
Arezzo, J.C.3
Bril, V.4
Feldman, E.L.5
Freeman, R.6
Malik, R.A.7
Maser, R.E.8
Sosenko, J.M.9
Ziegler, D.10
-
4
-
-
79953307499
-
Actovegin: A biological drug for more than 5 decades
-
Buchmayer F, Pleiner J, Elmlinger M et al. Actovegin: a biological drug for more than 5 decades. Wien Med Wochenschr: 2011; 161 3-4 80 88
-
(2011)
Wien Med Wochenschr
, vol.161
, Issue.34
, pp. 80-88
-
-
Buchmayer, F.1
Pleiner, J.2
Elmlinger, M.3
-
5
-
-
0035195970
-
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
-
DOI 10.1007/s001250100001
-
Cameron N E, Eaton S E, Cotter M A et al. Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia: 2001; 44 1973 1988 (Pubitemid 33124042)
-
(2001)
Diabetologia
, vol.44
, Issue.11
, pp. 1973-1988
-
-
Cameron, N.E.1
Eaton, S.E.M.2
Cotter, M.A.3
Tesfaye, S.4
-
6
-
-
0034741718
-
Effects of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes
-
DOI 10.1007/s001250100626
-
Cameron N E, Tuck Z, McCabe L et al. Effect of the hydroxyl radical scavenger, dimethylthiourea, on peripheral nerve tissue perfusion, conduction velocity and nociception in experimental diabetes. Diabetologia: 2001; 44 1161 1169 (Pubitemid 32835509)
-
(2001)
Diabetologia
, vol.44
, Issue.9
, pp. 1161-1169
-
-
Cameron, N.E.1
Tuck, Z.2
McCabe, L.3
Cotter, M.A.4
-
7
-
-
33947310739
-
Diabetic painful neuropathy: Current and future treatment options
-
DOI 10.2165/00003495-200767040-00006
-
Chong M S, Hester J. Diabetic painful neuropathy: current and future treatment options. Drugs: 2007; 67 569 585 (Pubitemid 46440313)
-
(2007)
Drugs
, vol.67
, Issue.4
, pp. 569-585
-
-
Chong, M.S.1
Hester, J.2
-
8
-
-
77954528687
-
New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}
-
Drel V R, Lupachyk S, Shevalye H et al. New therapeutic and biomarker discovery for peripheral diabetic neuropathy: PARP inhibitor, nitrotyrosine, and tumor necrosis factor-{alpha}. Endocrinology: 2010; 151 2547 2555
-
(2010)
Endocrinology
, vol.151
, pp. 2547-2555
-
-
Drel, V.R.1
Lupachyk, S.2
Shevalye, H.3
-
9
-
-
64649093418
-
Intranasal insulin ameliorates experimental diabetic neuropathy
-
Francis G, Martinez J, Liu W et al. Intranasal insulin ameliorates experimental diabetic neuropathy. Diabetes: 2009; 58 934 945
-
(2009)
Diabetes
, vol.58
, pp. 934-945
-
-
Francis, G.1
Martinez, J.2
Liu, W.3
-
10
-
-
0035136240
-
Diabetic endothelial dysfunction: The role of poly(ADP-ribose) polymerase activation
-
DOI 10.1038/83241
-
Garcia S F, Virag L, Jagtap P et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nat Med: 2001; 7 108 113 (Pubitemid 32095649)
-
(2001)
Nature Medicine
, vol.7
, Issue.1
, pp. 108-113
-
-
Garcia Soriano, F.1
Virag, L.2
Jagtap, P.3
Szabo, E.4
Mabley, J.G.5
Liaudet, L.6
Marton, A.7
Hoyt, D.G.8
Murthy, K.G.K.9
Salzman, A.L.10
Southan, G.J.11
Szabo, C.12
-
11
-
-
0030896839
-
Intraepidermal nerve fiber density in patients with painful sensory neuropathy
-
Holland N R, Stocks A, Hauer P et al. Intraepidermal nerve fiber density in patients with painful sensory neuropathy. Neurology: 1997; 48 708 711 (Pubitemid 27120111)
-
(1997)
Neurology
, vol.48
, Issue.3
, pp. 708-711
-
-
Holland, N.R.1
Stocks, A.2
Hauer, P.3
Cornblath, D.R.4
Griffin, J.W.5
McArthur, J.C.6
-
12
-
-
33748292845
-
Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy
-
DOI 10.2337/db06-0067
-
Ilnytska O, Lyzogubov V V, Stevens M J et al. Poly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathy. Diabetes: 2006; 55 1686 1694 (Pubitemid 44324121)
-
(2006)
Diabetes
, vol.55
, Issue.6
, pp. 1686-1694
-
-
Ilnytska, O.1
Lyzogubov, V.V.2
Stevens, M.J.3
Drel, V.R.4
Mashtalir, N.5
Pacher, P.6
Yorek, M.A.7
Obrosova, I.G.8
-
13
-
-
36849058141
-
Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes
-
DOI 10.2337/db07-0740
-
Kellogg A P, Wiggin T D, Larkin D D et al. Protective effects of cyclooxygenase-2 gene inactivation against peripheral nerve dysfunction and intraepidermal nerve fiber loss in experimental diabetes. Diabetes: 2007; 56 2997 3005 (Pubitemid 350223635)
-
(2007)
Diabetes
, vol.56
, Issue.12
, pp. 2997-3005
-
-
Kellogg, A.P.1
Wiggin, T.D.2
Larkin, D.D.3
Hayes, J.M.4
Stevens, M.J.5
Pop-Busui, R.6
-
14
-
-
0026080976
-
Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract
-
Kuninaka T, Senga Y, Senga H et al. Nature of enhanced mitochondrial oxidative metabolism by a calf blood extract. J Cell Physiol: 1991; 146 148 155 (Pubitemid 21910035)
-
(1991)
Journal of Cellular Physiology
, vol.146
, Issue.1
, pp. 148-155
-
-
Kuninaka, T.1
Senga, Y.2
Senga, H.3
Weiner, M.4
-
15
-
-
22144461459
-
Intraepidermal nerve fiber density in rat foot pad: Neuropathologic- neurophysiologic correlation
-
DOI 10.1111/j.1085-9489.2005.0010210.x
-
Lauria G, Lombardi R, Borgna M et al. Intraepidermal nerve fiber density in rat foot pad: neuropathologic-neurophysiologic correlation. J Peripher Nerv Syst 10: 2005; 10 202 208 (Pubitemid 40984894)
-
(2005)
Journal of the Peripheral Nervous System
, vol.10
, Issue.2
, pp. 202-208
-
-
Lauria, G.1
Lombardi, R.2
Borgna, M.3
Penza, P.4
Bianchi, R.5
Savino, C.6
Canta, A.7
Nicolini, G.8
Marmiroli, P.9
Cavaletti, G.10
-
16
-
-
33644681565
-
Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: The relation is revisited
-
DOI 10.2337/diabetes.54.12.3435
-
Obrosova I G, Drel V R, Pacher P et al. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy. Diabetes: 2005; 54 3435 3441 (Pubitemid 43334333)
-
(2005)
Diabetes
, vol.54
, Issue.12
, pp. 3435-3441
-
-
Obrosova, I.G.1
Drel, V.R.2
Pacher, P.3
Ilnytska, O.4
Wang, Z.Q.5
Stevens, M.J.6
Yorek, M.A.7
-
17
-
-
39849088155
-
PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy
-
DOI 10.1016/j.freeradbiomed.2007.09.013, PII S0891584907006284
-
Obrosova I G, Xu W, Lyzogubov V V et al. PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy. Free Radic Biol Med: 2008; 44 972 981 (Pubitemid 351318144)
-
(2008)
Free Radical Biology and Medicine
, vol.44
, Issue.6
, pp. 972-981
-
-
Obrosova, I.G.1
Xu, W.2
Lyzogubov, V.V.3
Ilnytska, O.4
Mashtalir, N.5
Vareniuk, I.6
Pavlov, I.A.7
Zhang, J.8
Slusher, B.9
Drel, V.R.10
-
18
-
-
0030022084
-
Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine
-
DOI 10.1007/s001250050440
-
Sagara M, Satoh J, Wada R et al. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia: 1996; 39 263 269 (Pubitemid 26064822)
-
(1996)
Diabetologia
, vol.39
, Issue.3
, pp. 263-269
-
-
Sagara, M.1
Satoh, J.2
Wada, R.3
Yagihashi, S.4
Takahashi, K.5
Fukuzawa, M.6
Muto, G.7
Muto, Y.8
Toyota, T.9
-
19
-
-
78651101592
-
Diabetic neuropathies: Update on definitions, diagnostic criteria, estimation of severity, and treatments
-
Tesfaye S, Boulton A J, Dyck P J et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care: 2010; 33 2285 2293
-
(2010)
Diabetes Care
, vol.33
, pp. 2285-2293
-
-
Tesfaye, S.1
Boulton, A.J.2
Dyck, P.J.3
-
20
-
-
33646437269
-
Remote neurotrophic support of epidermal nerve fibres in experimental diabetes
-
Toth C, Brussee V, Zochodne D W. Remote neurotrophic support of epidermal nerve fibres in experimental diabetes. Diabetologia: 2006; 49 1081 1088
-
(2006)
Diabetologia
, vol.49
, pp. 1081-1088
-
-
Toth, C.1
Brussee, V.2
Zochodne, D.W.3
-
21
-
-
34248560907
-
Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice
-
DOI 10.1016/j.expneurol.2007.03.019, PII S0014488607000969
-
Vareniuk I, Pavlov I A, Drel V R et al. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice. Exp Neurol: 2007; 205 425 436 (Pubitemid 46755764)
-
(2007)
Experimental Neurology
, vol.205
, Issue.2
, pp. 425-436
-
-
Vareniuk, I.1
Pavlov, I.A.2
Drel, V.R.3
Lyzogubov, V.V.4
Ilnytska, O.5
Bell, S.R.6
Tibrewala, J.7
Groves, J.T.8
Obrosova, I.G.9
-
22
-
-
68149106189
-
Treatment of Symptomatic Polyneuropathy with Actovegin in Type 2 Diabetic Patients
-
Ziegler D, Movsesyan L, Mankovsky B et al. Treatment of Symptomatic Polyneuropathy with Actovegin in Type 2 Diabetic Patients. Diabetes Care: 2009; 32 1479 1484
-
(2009)
Diabetes Care
, vol.32
, pp. 1479-1484
-
-
Ziegler, D.1
Movsesyan, L.2
Mankovsky, B.3
|